OCUDEX

This brand name is authorized in Nigeria.

Active ingredients

The drug OCUDEX contains one active pharmaceutical ingredient (API):

1	Dexamethasone UNII AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE
	Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.
	Read more about Dexamethasone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5175	Eye drops	Ocudex Eye Drops SOL_DROPS 0.1% 1 x 5 mL (in LDPE bottle)	Eye Drops 32 RNW-PP-200247 OCUDEX EYE DROPS DEXAMETHASONE SODIUM PHOSPHATE Dexamethasone Sodium Phosphate Ophthalmic Solution USP 0.1% w/v Excipient: Phenylmercuric Nitrate USP 0.001% w/v (as preservatives), Hydroxypropyl Methyl Cellulose BP 0.3% w/v, Water for Injection USP q.s B4-5175 Drugs Imported Products 5ml Prescription Only Medicine (POM) 2/9/2022 NOMEDI PHARMACEUTICALS LIMITED, 387 Agege motor road Mushin 17412135 victoria.ezeala@nomedipharma-ng.com ADORE PHARMACEUTICALS PVT LTD, 5/6, KHOKANI INDUsTRIAL COMPLEX NO. 2, SATIVALI, VASAI (EAST). DIST, TANE - 4O12OB. INDIA, India	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BA01	Dexamethasone	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5175